The Latest Cardiac and Vascular News
SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, today announced the pricing of its initial public offering of 2,750,000 units, each consisting of (i) one share of common stock and (ii) one […]
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the initiation of VICTOR (VerICiguaT in adults with ChrOnic heart failure and Reduced ejection fraction), a pivotal Phase 3 randomized, placebo-controlled cardiovascular clinical trial of VERQUVO® (vericiguat) in patients with chronic heart failure and reduced ejection fraction of 40% […]
Announced topline data from Phase 2b clinical trial of bentracimab, which was conducted in healthy, older volunteers 50-80 years old Reached interim enrollment milestone for the REVERSE-IT Phase 3 trial of bentracimab Prespecified interim analysis of pivotal REVERSE-IT Phase 3 trial to be presented during late-breaking science session on November […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease, announced today the appointment of Dr. Matthew Thompson, as President and Chief Executive Officer. Dr. Thompson will also join Endologix’s Board of Directors. […]
– FDA 510(k) Clearance Creates Multi-Vendor, One Click MRI™ Automation Platform to Increase Real-Time MRI Imaging Access and Accuracy for Patients – New AHA and ACC Guidelines, Making Cardiac MRI a Class I Recommendation for Chest Pain, Will Increase CMR Use to Widely Impact the Practice of Cardiology PALO ALTO, Calif.–(BUSINESS WIRE)–HeartVista, […]
The companies will offer a combined solution to mitigate a major complication following cardiac surgery NEW YORK, Nov. 10, 2021 /PRNewswire/ — Peerbridge Health and Native Cardio Inc. recognize the postoperative challenges the 500,000+ cardiac surgery patients in the US face each year, with more than 20% developing postoperative atrial fibrillation (POAF). To […]
Continuous monitoring device with advanced features and analytics to deliver personalized insights directly to the smartphone REDWOOD CITY, Calif.–(BUSINESS WIRE)–Biotricity, Inc. (NASDAQ:BTCY), a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions, today announced the availability of Bioheart, a direct-to-consumer heart monitor that offers the same continuous heart monitoring technology […]
ENGLEWOOD, Colo., Nov. 10, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has declared a one-time special cash dividend of $0.10 per share and a stock dividend of 10% […]
LILLESAND, Norway, Nov. 10, 2021 /PRNewswire/ — The innovative heart sensor ECG247, which has been developed and manufactured by Appsens AS in Norway, is shown to be better than the equipment most of the world’s hospitals and heart specialists use to find heart rhythm disorders, according to a new study published in the renowned […]
ANDOVER, Mass., Nov. 9, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended September 30, 2021. Recent Highlights Net revenue of $5.4 million in the third quarter of 2021, a […]
